Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sethuraman Natarajan
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WENTWORTH KORY JAMES
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WENTWORTH KORY JAMES
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dowden Nathan J
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WENTWORTH KORY JAMES
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dowden Nathan J
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sethuraman Natarajan
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Entrada Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(3.8%),Jeremy C. Green(3.8%)
Entrada Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Roche Finance Ltd(8.2%),Roche Holding Ltd(8.2%)
Entrada Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(9.0%)
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
No Data